BLVRA, biliverdin reductase A, 644

N. diseases: 34; N. variants: 5
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs387906595
rs387906595
Entrez Id: 644;102724946
Gene Symbol: BLVRA;LOC102724946
BLVRA;LOC102724946
CUI: C3279964
Disease:
Hyperbiliverdinemia
T 0.700 CausalMutation CLINVAR
dbSNP: rs387906596
rs387906596
Entrez Id: 644;102724946
Gene Symbol: BLVRA;LOC102724946
BLVRA;LOC102724946
CUI: C3279964
Disease:
Hyperbiliverdinemia
A 0.700 CausalMutation CLINVAR
dbSNP: rs699512
rs699512
Entrez Id: 644;102724946
Gene Symbol: BLVRA;LOC102724946
BLVRA;LOC102724946
CUI: C0857007
Disease:
Hyperbilirubinemia, Neonatal
0.010 GeneticVariation BEFREE Genetic variants of bilirubin metabolism genes, including G6PD 1388 G>A, SLCO1B1 rs4149056 and BLVRA rs699512, are associated with the risk of neonatal hyperbilirubinaemia, and are potential markers for predicting the disorder. 30636082 2019
dbSNP: rs699512
rs699512
Entrez Id: 644;102724946
Gene Symbol: BLVRA;LOC102724946
BLVRA;LOC102724946
CUI: C0085580
Disease:
Essential Hypertension
0.010 GeneticVariation BEFREE Therefore, we hypothesized that BLVRA might be attributable to the variation of susceptibility to essential hypertension, and investigated single nucleotide polymorphism (SNP) rs699512 (Thr3Ala), the only common non-synonymous SNP within BLVRA, in population-based samples of 999 Kazak herdsmen from the villages in Xinjiang, China. 21721974 2011
dbSNP: rs2690381
rs2690381
Entrez Id: 644;102724946
Gene Symbol: BLVRA;LOC102724946
BLVRA;LOC102724946
CUI: C1956346
Disease:
Coronary Artery Disease
0.010 GeneticVariation BEFREE Four significant associations with CAD were detected after controlling age and the false discovery rate at 15%: the recessive effect of SNP rs887829 (UGT1A1 G-364A) [age-adjusted odds ratio (OR): 0.24; 95% confidence interval (CI): 0.10-0.60; P=0.0014] and dominant effect of rs4149013 (SLCO1B1 A-12099G) (age-adjusted OR: 0.70; 95% CI: 0.55-0.91; P=0.0069) on male CAD, and the additive effects of rs2877262 (BLVRA G+1238/in6C) (age-adjusted OR: 0.73; 95% CI: 0.59-0.89; P=0.0021) and rs2690381 (BLVRA G+2613/in6A) (age-adjusted OR: 0.70; 95% CI: 0.56-0.86; P=0.0008) on female CAD. 19238116 2009
dbSNP: rs2877262
rs2877262
Entrez Id: 644;102724946
Gene Symbol: BLVRA;LOC102724946
BLVRA;LOC102724946
CUI: C1956346
Disease:
Coronary Artery Disease
0.010 GeneticVariation BEFREE Four significant associations with CAD were detected after controlling age and the false discovery rate at 15%: the recessive effect of SNP rs887829 (UGT1A1 G-364A) [age-adjusted odds ratio (OR): 0.24; 95% confidence interval (CI): 0.10-0.60; P=0.0014] and dominant effect of rs4149013 (SLCO1B1 A-12099G) (age-adjusted OR: 0.70; 95% CI: 0.55-0.91; P=0.0069) on male CAD, and the additive effects of rs2877262 (BLVRA G+1238/in6C) (age-adjusted OR: 0.73; 95% CI: 0.59-0.89; P=0.0021) and rs2690381 (BLVRA G+2613/in6A) (age-adjusted OR: 0.70; 95% CI: 0.56-0.86; P=0.0008) on female CAD. 19238116 2009